Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibody

Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibody

US Patent 9562095 · Granted Feb 7, 2017

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2025
Treating non-alcoholic steatohepatitis with cck inhibitors2025
Compositions and methods for preventing tumors and cancer2024
Compositions and methods for inducing humoral and cellular immunities against tu2024
Nanoparticle to target cancer2023
Compositions and methods for inducing humoral and cellular immunities against tu2023
Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2022
Nanoparticle to target cancer2022
Combinatorial therapies for the treatment of neoplasias using the opioid growth 2020
Combinatorial therapies for the treatment of neoplasias using the opioid growth 2016
Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting 2015
Composition and method for the treatment of gastrin mediated cancers2014